Discovery of Benzo[d]imidazole-6-sulfonamides as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain. (2022)
Attributed to:
ZMYND8-regulation of MITF as potential therapeutic target in melanoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cmdc.202200343
PubMed Identifier: 36040095
Publication URI: http://europepmc.org/abstract/MED/36040095
Type: Journal Article/Review
Volume: 17
Parent Publication: ChemMedChem
Issue: 20
ISSN: 1860-7179